FDA to Reclassify Home Uterine Activity Monitor from Class III to Class II

Summary

The FDA is seeking public comment on a recommendation to reclassify the home uterine activity monitor from a Class III device to a Class II device, following a petition from Corometrics Medical Systems, Inc. and review of publicly available information.